Curocell Inc. (KOSDAQ:372320)
South Korea
· Delayed Price · Currency is KRW
64,400
+2,000 (3.21%)
At close: Apr 28, 2026
Curocell Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cost of Revenue | 19.6 | 10.49 | 14.19 |
| Gross Profit | -19.6 | -10.49 | -14.19 |
| Selling, General & Admin | 4,623 | 4,632 | 3,821 |
| Research & Development | 31,251 | 31,864 | 27,191 |
| Amortization of Goodwill & Intangibles | 87.46 | 3.87 | 1.5 |
| Other Operating Expenses | 185.29 | 14.51 | 11.22 |
| Operating Expenses | 36,270 | 36,614 | 31,116 |
| Operating Income | -36,290 | -36,624 | -31,130 |
| Interest Expense | -4,544 | -2,603 | -2,431 |
| Interest & Investment Income | 457.72 | 938.26 | 617.54 |
| Currency Exchange Gain (Loss) | 37.42 | -24.34 | -14.64 |
| Other Non Operating Income (Expenses) | -5,976 | 83.35 | 3,305 |
| EBT Excluding Unusual Items | -46,314 | -38,230 | -29,652 |
| Gain (Loss) on Sale of Assets | 9.17 | -8.18 | -11.24 |
| Pretax Income | -46,305 | -38,238 | -29,664 |
| Income Tax Expense | - | 1.1 | -88.73 |
| Net Income | -46,305 | -38,239 | -29,575 |
| Net Income to Common | -46,305 | -38,239 | -29,575 |
| Shares Outstanding (Basic) | 14 | 14 | 12 |
| Shares Outstanding (Diluted) | 14 | 14 | 12 |
| Shares Change (YoY) | 2.51% | 18.11% | - |
| EPS (Basic) | -3232.00 | -2736.00 | -2499.18 |
| EPS (Diluted) | -3232.00 | -2736.00 | -2499.18 |
| Free Cash Flow | -30,306 | -28,973 | -46,428 |
| Free Cash Flow Per Share | -2115.32 | -2072.99 | -3923.32 |
| EBITDA | -30,168 | -30,289 | -26,424 |
| D&A For EBITDA | 6,122 | 6,335 | 4,706 |
| EBIT | -36,290 | -36,624 | -31,130 |
| Advertising Expenses | 70.63 | 43.48 | 45.38 |
Source: S&P Capital IQ. Standard template.
Financial Sources.